menu
    • menu
    [{"orgOrder":0,"company":"Haisco Pharmaceutical","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"CHINA","productType":"Miscellaneous","year":"2025","type":"Inapplicable","leadProduct":"Cofrogliptin","moa":"DPP-4","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Haisco Pharmaceutical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Haisco Pharmaceutical \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Haisco Pharmaceutical \/ Undisclosed"},{"orgOrder":0,"company":"The People's Hospital of Gaozhou","sponsor":"Chengdu Qingshan Likang Pharmaceutical","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Miscellaneous","year":"2025","type":"Inapplicable","leadProduct":"Amino Acids Mixture","moa":"Amino acid metabolism","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"The People's Hospital of Gaozhou","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"The People's Hospital of Gaozhou \/ Chengdu Qingshan Likang Pharmaceutical","highestDevelopmentStatusID":"1","companyTruncated":"The People's Hospital of Gaozhou \/ Chengdu Qingshan Likang Pharmaceutical"},{"orgOrder":0,"company":"Lo.Li.Pharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"FRANCE","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Inositol","moa":"Amyloid beta A4 protein (APP)","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Lo.Li.Pharma","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Lo.Li.Pharma \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Lo.Li.Pharma \/ Undisclosed"},{"orgOrder":0,"company":"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","sponsor":"ZonMw","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Inositol","moa":"Amyloid beta A4 protein (APP)","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation \/ ZonMw","highestDevelopmentStatusID":"1","companyTruncated":"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation \/ ZonMw"},{"orgOrder":0,"company":"Helmholtz Zentrum M\u00fcnchen","sponsor":"Technical University of Munich | Kinderkrankenhaus auf der Bult | University Hospital Carl Gustav Carus | Skane University Hospital | Universitaire Ziekenhuizen KU Leuven | Medical University of Warsaw | Cambridge Biomedical Campus, Cambridge, UK | Royal ","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"GERMANY","productType":"Probiotic","year":"2021","type":"Inapplicable","leadProduct":"Bifidobacterium Infantis","moa":"Bacteria microbiome","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Helmholtz Zentrum M\u00fcnchen","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Helmholtz Zentrum M\u00fcnchen \/ Technical University of Munich | Kinderkrankenhaus auf der Bult | University Hospital Carl Gustav Carus | Skane University Hospital | Universitaire Ziekenhuizen KU Leuven | Medical University of Warsaw | Cambridge Biomedical Campus, Cambridge, UK | Royal ","highestDevelopmentStatusID":"1","companyTruncated":"Helmholtz Zentrum M\u00fcnchen \/ Technical University of Munich | Kinderkrankenhaus auf der Bult | University Hospital Carl Gustav Carus | Skane University Hospital | Universitaire Ziekenhuizen KU Leuven | Medical University of Warsaw | Cambridge Biomedical Campus, Cambridge, UK | Royal "},{"orgOrder":0,"company":"Richmond Pharmacology","sponsor":"Richmond Research Institute","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"UNITED KINGDOM","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Glucose","moa":"Blood glucose level","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Richmond Pharmacology","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Richmond Pharmacology \/ Richmond Research Institute","highestDevelopmentStatusID":"1","companyTruncated":"Richmond Pharmacology \/ Richmond Research Institute"},{"orgOrder":0,"company":"Christopher Bell","sponsor":"Caliper Foods","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Controlled Substance","year":"2022","type":"Inapplicable","leadProduct":"Cannabidiol","moa":"Cannabinoid CB1 receptor","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Christopher Bell","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Powder","sponsorNew":"Christopher Bell \/ Caliper Foods","highestDevelopmentStatusID":"1","companyTruncated":"Christopher Bell \/ Caliper Foods"},{"orgOrder":0,"company":"Lo.Li.Pharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"FRANCE","productType":"Miscellaneous","year":"2021","type":"Inapplicable","leadProduct":"Levocarnitine","moa":"Carnitine O-palmitoyltransferase 1, muscle isoform; Xanthine dehydrogenase\/oxidase; Liver carboxylesterase 1; Myeloperoxidase; Carnitine O-palmitoyltransferase 1, liver isoform; Solute carrier family 22 member 4; Organic cation\/carnitine transporter 2; Carnitine O-acetyltransferase; Mitochondrial basic amino acids transporter; Mitochondrial carnitine\/acylcarnitine carrier protein; Peroxisomal carnitine O-octanoyltransferase; Carnitine O-palmitoyltransferase 2, mitochondrial","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Lo.Li.Pharma","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Lo.Li.Pharma \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Lo.Li.Pharma \/ Undisclosed"},{"orgOrder":0,"company":"Maastricht University Medical Center","sponsor":"Nutricia Inc","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"NETHERLANDS","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2020","type":"Inapplicable","leadProduct":"L-Arginine","moa":"Cationic amino acid transporter 3; Antizyme inhibitor 2; Argininosuccinate lyase; Nitric oxide synthase, inducible; High affinity cationic amino acid transporter 1; Arginase-2, mitochondrial; Cationic amino acid transporter 4; Argininosuccinate synthase; Nitric oxide synthase 3","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Maastricht University Medical Center","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Maastricht University Medical Center \/ Nutricia Inc","highestDevelopmentStatusID":"1","companyTruncated":"Maastricht University Medical Center \/ Nutricia Inc"},{"orgOrder":0,"company":"Centre for Addiction and Mental Health","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"CANADA","productType":"Miscellaneous","year":"2024","type":"Inapplicable","leadProduct":"Olanzapine","moa":"D2-like dopamine receptor | Serotonin 2a (5-HT2a) receptor | Serotonin 2c (5-HT2c) receptor","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Centre for Addiction and Mental Health","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Centre for Addiction and Mental Health \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Centre for Addiction and Mental Health \/ Undisclosed"},{"orgOrder":0,"company":"Alfred E Tiefenbacher GmbH","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"GERMANY","productType":"Miscellaneous","year":"2022","type":"Inapplicable","leadProduct":"Vildagliptin","moa":"Dipeptidyl peptidase IV","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Alfred E Tiefenbacher GmbH","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Alfred E Tiefenbacher GmbH \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Alfred E Tiefenbacher GmbH \/ Undisclosed"},{"orgOrder":0,"company":"Sunnybrook Health Sciences Centre","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"CANADA","productType":"Enzyme","year":"2022","type":"Inapplicable","leadProduct":"Lipase","moa":"Fatty acids","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Sunnybrook Health Sciences Centre","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Sunnybrook Health Sciences Centre \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Sunnybrook Health Sciences Centre \/ Undisclosed"},{"orgOrder":0,"company":"Corporacion Parc Tauli","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SPAIN","productType":"Peptide, Unconjugated","year":"2021","type":"Inapplicable","leadProduct":"Dulaglutide","moa":"Glucagon-like peptide 1 receptor","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Corporacion Parc Tauli","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Corporacion Parc Tauli \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Corporacion Parc Tauli \/ Undisclosed"},{"orgOrder":0,"company":"Vastra Gotaland Region","sponsor":"Swedish Society of Medicine | \u00c5ke Wibergs Stiftelse | Sahlgrenska University Hospital | Pilloxa","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SWEDEN","productType":"Steroid","year":"2023","type":"Inapplicable","leadProduct":"Hydrocortisone","moa":"Glucocorticoid receptor","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Vastra Gotaland Region","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Vastra Gotaland Region \/ Swedish Society of Medicine | \u00c5ke Wibergs Stiftelse | Sahlgrenska University Hospital | Pilloxa","highestDevelopmentStatusID":"1","companyTruncated":"Vastra Gotaland Region \/ Swedish Society of Medicine | \u00c5ke Wibergs Stiftelse | Sahlgrenska University Hospital | Pilloxa"},{"orgOrder":0,"company":"Evotec","sponsor":"Ildong Pharmaceutical","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"GERMANY","productType":"Miscellaneous","year":"2020","type":"Collaboration","leadProduct":"IDG16177","moa":"GPR40","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Evotec","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Evotec \/ Ildong Pharmaceutical","highestDevelopmentStatusID":"1","companyTruncated":"Evotec \/ Ildong Pharmaceutical"},{"orgOrder":0,"company":"Wecare Probiotics Co., Ltd.","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"CHINA","productType":"Probiotic","year":"2024","type":"Inapplicable","leadProduct":"Probiotic","moa":"Immune","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Wecare Probiotics Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Wecare Probiotics Co., Ltd. \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Wecare Probiotics Co., Ltd. \/ Undisclosed"},{"orgOrder":0,"company":"Fundaci\u00f3n IVI","sponsor":"ADM Protexin | Biopolis S.L. | Instituto Valenciano de Infertilidad, IVI VALENCIA","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SPAIN","productType":"Probiotic","year":"2020","type":"Inapplicable","leadProduct":"Probiotic","moa":"Immune","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Fundaci\u00f3n IVI","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Fundaci\u00f3n IVI \/ ADM Protexin | Biopolis S.L. | Instituto Valenciano de Infertilidad, IVI VALENCIA","highestDevelopmentStatusID":"1","companyTruncated":"Fundaci\u00f3n IVI \/ ADM Protexin | Biopolis S.L. | Instituto Valenciano de Infertilidad, IVI VALENCIA"},{"orgOrder":0,"company":"BEAUTECH","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Cell & Gene Therapy","year":"2024","type":"Inapplicable","leadProduct":"Wharton\u2019S Jelly Derived Mesenchymal Stem Cell","moa":"Immune","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"BEAUTECH","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"BEAUTECH \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"BEAUTECH \/ Undisclosed"},{"orgOrder":0,"company":"Medtrum","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"CHINA","productType":"Hormone","year":"2020","type":"Inapplicable","leadProduct":"Insulin","moa":"Insulin receptor","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Medtrum","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Medtrum \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Medtrum \/ Undisclosed"},{"orgOrder":0,"company":"Diabeloop","sponsor":"Novo Nordisk","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"FRANCE","productType":"Hormone","year":"2023","type":"Collaboration","leadProduct":"Insulin","moa":"Insulin receptor","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Diabeloop","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Diabeloop \/ Novo Nordisk","highestDevelopmentStatusID":"1","companyTruncated":"Diabeloop \/ Novo Nordisk"},{"orgOrder":0,"company":"University of Calgary","sponsor":"Calgary Health Trust | Medtronic plc | Ward of the 21st Century","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"CANADA","productType":"Hormone","year":"2020","type":"Inapplicable","leadProduct":"Insulin","moa":"Insulin receptor","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"University of Calgary","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Calgary \/ Calgary Health Trust | Medtronic plc | Ward of the 21st Century","highestDevelopmentStatusID":"1","companyTruncated":"University of Calgary \/ Calgary Health Trust | Medtronic plc | Ward of the 21st Century"},{"orgOrder":0,"company":"Civica Rx","sponsor":"CalRx Biosimilar Insulin Initiative","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Hormone","year":"2023","type":"Partnership","leadProduct":"Insulin","moa":"Insulin receptor","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Civica Rx","amount2":0.050000000000000003,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0.050000000000000003,"dosageForm":"Injection","sponsorNew":"Civica Rx \/ CalRx Biosimilar Insulin Initiative","highestDevelopmentStatusID":"1","companyTruncated":"Civica Rx \/ CalRx Biosimilar Insulin Initiative"},{"orgOrder":0,"company":"HEC Group","sponsor":"Lannett Company, Inc.","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"CANADA","productType":"Hormone","year":"2021","type":"Collaboration","leadProduct":"Insulin aspart","moa":"Insulin receptor","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"HEC Group","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Injection","sponsorNew":"HEC Group \/ Lannett Company, Inc.","highestDevelopmentStatusID":"1","companyTruncated":"HEC Group \/ Lannett Company, Inc."},{"orgOrder":0,"company":"Ypsomed","sponsor":"Civica Rx","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"SWITZERLAND","productType":"Peptide, Unconjugated","year":"2023","type":"Partnership","leadProduct":"Insulin Glargine","moa":"Insulin receptor","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Ypsomed","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Ypsomed \/ Civica Rx","highestDevelopmentStatusID":"1","companyTruncated":"Ypsomed \/ Civica Rx"},{"orgOrder":0,"company":"Inreda Diabetic","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"NETHERLANDS","productType":"Peptide, Unconjugated","year":"2022","type":"Inapplicable","leadProduct":"Insulin Lispro","moa":"Insulin receptor","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Inreda Diabetic","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Inreda Diabetic \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Inreda Diabetic \/ Undisclosed"},{"orgOrder":0,"company":"Kyu Chang Won","sponsor":"Boryung Pharmaceutical Co., Ltd | Dong-A ST Co., Ltd. | HK inno.N | Daewoong Pharmaceutical | Chong Kun Dang Pharm | Celltrion | Kakao Healthcare | HANDOK","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Miscellaneous","year":"2024","type":"Inapplicable","leadProduct":"Metformin","moa":"Mitochondrial complex I (NADH dehydrogenase)","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Kyu Chang Won","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyu Chang Won \/ Boryung Pharmaceutical Co., Ltd | Dong-A ST Co., Ltd. | HK inno.N | Daewoong Pharmaceutical | Chong Kun Dang Pharm | Celltrion | Kakao Healthcare | HANDOK","highestDevelopmentStatusID":"1","companyTruncated":"Kyu Chang Won \/ Boryung Pharmaceutical Co., Ltd | Dong-A ST Co., Ltd. | HK inno.N | Daewoong Pharmaceutical | Chong Kun Dang Pharm | Celltrion | Kakao Healthcare | HANDOK"},{"orgOrder":0,"company":"Elaine Chow","sponsor":"Merck Group","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Miscellaneous","year":"2022","type":"Inapplicable","leadProduct":"Metformin","moa":"Mitochondrial complex I (NADH dehydrogenase)","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Elaine Chow","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Elaine Chow \/ Merck Group","highestDevelopmentStatusID":"1","companyTruncated":"Elaine Chow \/ Merck Group"},{"orgOrder":0,"company":"Appalachian State University","sponsor":"LycoRed Ltd.","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2022","type":"Inapplicable","leadProduct":"Astaxanthin","moa":"NF-kappa-B inhibitor alpha","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Appalachian State University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Appalachian State University \/ LycoRed Ltd.","highestDevelopmentStatusID":"1","companyTruncated":"Appalachian State University \/ LycoRed Ltd."},{"orgOrder":0,"company":"University of Bath","sponsor":"Arla Foods","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"UNITED KINGDOM","productType":"Protein","year":"2020","type":"Inapplicable","leadProduct":"Protein","moa":"Protein","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"University of Bath","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Bath \/ Arla Foods","highestDevelopmentStatusID":"1","companyTruncated":"University of Bath \/ Arla Foods"},{"orgOrder":0,"company":"Brigham and Women's Hospital","sponsor":"Tersus Life Sciences LLC","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Miscellaneous","year":"2022","type":"Inapplicable","leadProduct":"Palmitoleic Acid","moa":"Pseudomonas UDP-3-O-acyl-GlcNAc deacetylase (Pseudo lpxC)","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Brigham and Women's Hospital","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Brigham and Women's Hospital \/ Tersus Life Sciences LLC","highestDevelopmentStatusID":"1","companyTruncated":"Brigham and Women's Hospital \/ Tersus Life Sciences LLC"},{"orgOrder":0,"company":"Zucara Therapeutics","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"CANADA","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"ZT-01","moa":"SST2 receptor","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Zucara Therapeutics","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Zucara Therapeutics \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Zucara Therapeutics \/ Undisclosed"},{"orgOrder":0,"company":"Dasman Diabetes Institute","sponsor":"Kappa Bioscience","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"KUWAIT","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2022","type":"Inapplicable","leadProduct":"Vitamin K2","moa":"Trypanosoma Cruzipain (Trypano CYSP)","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Dasman Diabetes Institute","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Dasman Diabetes Institute \/ Kappa Bioscience","highestDevelopmentStatusID":"1","companyTruncated":"Dasman Diabetes Institute \/ Kappa Bioscience"},{"orgOrder":0,"company":"Brightseed","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2024","type":"Inapplicable","leadProduct":"N-Trans-Caffeoyltyramine","moa":"Tyrosinase; Peptide deformylase","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Brightseed","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Brightseed \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Brightseed \/ Undisclosed"},{"orgOrder":0,"company":"NATURAL WELLNESS INDUSTRIES SDN. BHD","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"MALAYSIA","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Natural Wellness Low-Glu","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"NATURAL WELLNESS INDUSTRIES SDN. BHD","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"NATURAL WELLNESS INDUSTRIES SDN. BHD \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"NATURAL WELLNESS INDUSTRIES SDN. BHD \/ Undisclosed"},{"orgOrder":0,"company":"Vedic Lifesciences","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"INDIA","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"Terminalia Arjuna","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Vedic Lifesciences","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Vedic Lifesciences \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Vedic Lifesciences \/ Undisclosed"},{"orgOrder":0,"company":"Mar\u00eda Isabel Espinosa","sponsor":"Biomedical Research Institute Sols-Morreale (CSIC-UAM) | Centro de Biolog\u00c3-a Molecular Severo Ochoa, Spain | Epidisease S.L | NUTRINSECT","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Acheta Domesticus","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Mar\u00eda Isabel Espinosa","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Mar\u00eda Isabel Espinosa \/ Biomedical Research Institute Sols-Morreale (CSIC-UAM) | Centro de Biolog\u00c3-a Molecular Severo Ochoa, Spain | Epidisease S.L | NUTRINSECT","highestDevelopmentStatusID":"1","companyTruncated":"Mar\u00eda Isabel Espinosa \/ Biomedical Research Institute Sols-Morreale (CSIC-UAM) | Centro de Biolog\u00c3-a Molecular Severo Ochoa, Spain | Epidisease S.L | NUTRINSECT"},{"orgOrder":0,"company":"Alcresta Therapeutics","sponsor":"Linden Capital Partners","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Miscellaneous","year":"2024","type":"Acquisition","leadProduct":"ALC-079","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Alcresta Therapeutics","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Alcresta Therapeutics \/ Linden Capital Partners","highestDevelopmentStatusID":"1","companyTruncated":"Alcresta Therapeutics \/ Linden Capital Partners"},{"orgOrder":0,"company":"Standard Process Inc.","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Alpha-GPC","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Standard Process Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Standard Process Inc. \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Standard Process Inc. \/ Nutrasource"},{"orgOrder":0,"company":"Singapore Institute of Food and Biotechnology Innovation","sponsor":"Prince September Pte. Ltd.","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Animal Meat","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Singapore Institute of Food and Biotechnology Innovation","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Singapore Institute of Food and Biotechnology Innovation \/ Prince September Pte. Ltd.","highestDevelopmentStatusID":"1","companyTruncated":"Singapore Institute of Food and Biotechnology Innovation \/ Prince September Pte. Ltd."},{"orgOrder":0,"company":"SunWay Biotech","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"TAIWAN","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Ankascin 568-P Red Yeast Rice","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"SunWay Biotech","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"SunWay Biotech \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"SunWay Biotech \/ Undisclosed"},{"orgOrder":0,"company":"AMOREPACIFIC CORPORATION","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SOUTH KOREA","productType":"Plant Extract\/Herbal","year":"2021","type":"Inapplicable","leadProduct":"Ap Green Tea Extract","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"AMOREPACIFIC CORPORATION","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"AMOREPACIFIC CORPORATION \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"AMOREPACIFIC CORPORATION \/ Undisclosed"},{"orgOrder":0,"company":"AronPharma Sp. z o. o.","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"POLAND","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"AP029","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"AronPharma Sp. z o. o.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"AronPharma Sp. z o. o. \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"AronPharma Sp. z o. o. \/ Undisclosed"},{"orgOrder":0,"company":"Lund University","sponsor":"Carbiotix AB | Skane University Hospital | Vinnova","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SWEDEN","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Arabinoxylan","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Lund University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Lund University \/ Carbiotix AB | Skane University Hospital | Vinnova","highestDevelopmentStatusID":"1","companyTruncated":"Lund University \/ Carbiotix AB | Skane University Hospital | Vinnova"},{"orgOrder":0,"company":"Azienda di Servizi alla Persona di Pavia","sponsor":"Indena","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"ITALY","productType":"Plant Extract\/Herbal","year":"2020","type":"Inapplicable","leadProduct":"Artichoke Extract","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Azienda di Servizi alla Persona di Pavia","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Azienda di Servizi alla Persona di Pavia \/ Indena","highestDevelopmentStatusID":"1","companyTruncated":"Azienda di Servizi alla Persona di Pavia \/ Indena"},{"orgOrder":0,"company":"Nestle Health Sciences SA","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SWITZERLAND","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Betaquik","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Nestle Health Sciences SA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nestle Health Sciences SA \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Nestle Health Sciences SA \/ Undisclosed"},{"orgOrder":0,"company":"Midwest Center for Metabolic and Cardiovascular Research","sponsor":"Greenyn Biotechnology","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2022","type":"Inapplicable","leadProduct":"Bitter Melon","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Midwest Center for Metabolic and Cardiovascular Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Midwest Center for Metabolic and Cardiovascular Research \/ Greenyn Biotechnology","highestDevelopmentStatusID":"1","companyTruncated":"Midwest Center for Metabolic and Cardiovascular Research \/ Greenyn Biotechnology"},{"orgOrder":0,"company":"BioKier","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Dietary Supplement","year":"2020","type":"Inapplicable","leadProduct":"BKR-017","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"BioKier","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"BioKier \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"BioKier \/ Undisclosed"},{"orgOrder":0,"company":"BioKier","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Dietary Supplement","year":"2020","type":"Inapplicable","leadProduct":"BKR-017","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"BioKier","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"BioKier \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"BioKier \/ Undisclosed"},{"orgOrder":0,"company":"University of Aarhus","sponsor":"Future Food Innovation","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"DENMARK","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"Brassica Oleracea Var. Acephala","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"University of Aarhus","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Aarhus \/ Future Food Innovation","highestDevelopmentStatusID":"1","companyTruncated":"University of Aarhus \/ Future Food Innovation"},{"orgOrder":0,"company":"Taipei Medical University WanFang Hospital","sponsor":"Hi-Q Marine Biotech","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"TAIWAN","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Brown Seaweed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Taipei Medical University WanFang Hospital","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Taipei Medical University WanFang Hospital \/ Hi-Q Marine Biotech","highestDevelopmentStatusID":"1","companyTruncated":"Taipei Medical University WanFang Hospital \/ Hi-Q Marine Biotech"},{"orgOrder":0,"company":"Helsinki University Central Hospital","sponsor":"Dexcom","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"FINLAND","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"CGM","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Helsinki University Central Hospital","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Helsinki University Central Hospital \/ DexCom","highestDevelopmentStatusID":"1","companyTruncated":"Helsinki University Central Hospital \/ DexCom"},{"orgOrder":0,"company":"Chang Gung Memorial Hospital","sponsor":"Zhao Hong Biotechnology Co., Ltd.","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"TAIWAN","productType":"Protein","year":"2020","type":"Inapplicable","leadProduct":"Clam Protein","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Chang Gung Memorial Hospital","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Chang Gung Memorial Hospital \/ Zhao Hong Biotechnology Co., Ltd.","highestDevelopmentStatusID":"1","companyTruncated":"Chang Gung Memorial Hospital \/ Zhao Hong Biotechnology Co., Ltd."},{"orgOrder":0,"company":"Rousselot BVBA","sponsor":"BioTeSys GmbH","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"BELGIUM","productType":"Protein","year":"2023","type":"Inapplicable","leadProduct":"Collagen Peptide","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Rousselot BVBA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Rousselot BVBA \/ BioTeSys GmbH","highestDevelopmentStatusID":"1","companyTruncated":"Rousselot BVBA \/ BioTeSys GmbH"},{"orgOrder":0,"company":"Rousselot BVBA","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"BELGIUM","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Collagen Hydrolyzed Peptides","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Rousselot BVBA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Rousselot BVBA \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Rousselot BVBA \/ Undisclosed"},{"orgOrder":0,"company":"Appalachian State University","sponsor":"Ocean Spray, Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2022","type":"Inapplicable","leadProduct":"Cranberry Juice","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Appalachian State University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Appalachian State University \/ Ocean Spray, Inc.","highestDevelopmentStatusID":"1","companyTruncated":"Appalachian State University \/ Ocean Spray, Inc."},{"orgOrder":0,"company":"Universiti Putra Malaysia","sponsor":"Matsutani Chemical Industry Co., Ltd. | Kagawa University","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"MALAYSIA","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"D-Allulose","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Universiti Putra Malaysia","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Universiti Putra Malaysia \/ Matsutani Chemical Industry Co., Ltd. | Kagawa University","highestDevelopmentStatusID":"1","companyTruncated":"Universiti Putra Malaysia \/ Matsutani Chemical Industry Co., Ltd. | Kagawa University"},{"orgOrder":0,"company":"Lo.Li.Pharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"FRANCE","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"D-Chiroinositol","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Lo.Li.Pharma","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Lo.Li.Pharma \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Lo.Li.Pharma \/ Undisclosed"},{"orgOrder":0,"company":"Ultimate International, Inc.","sponsor":"Citruslabs","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Diaberine","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Ultimate International, Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Ultimate International, Inc. \/ Citruslabs","highestDevelopmentStatusID":"1","companyTruncated":"Ultimate International, Inc. \/ Citruslabs"},{"orgOrder":0,"company":"Atlantia Food Clinical Trials","sponsor":"Caelus Pharmaceuticals BV","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Dietary Supplement","year":"2020","type":"Inapplicable","leadProduct":"Eubacterium Hallii","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Atlantia Food Clinical Trials","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Atlantia Food Clinical Trials \/ Caelus Pharmaceuticals BV","highestDevelopmentStatusID":"1","companyTruncated":"Atlantia Food Clinical Trials \/ Caelus Pharmaceuticals BV"},{"orgOrder":0,"company":"Lo.Li.Pharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"FRANCE","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Eudiamet","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Lo.Li.Pharma","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Lo.Li.Pharma \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Lo.Li.Pharma \/ Undisclosed"},{"orgOrder":0,"company":"Defymed","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"FRANCE","productType":"Miscellaneous","year":"2022","type":"Inapplicable","leadProduct":"Exolin","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Defymed","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Implant","sponsorNew":"Defymed \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Defymed \/ Undisclosed"},{"orgOrder":0,"company":"MetaboGen AB","sponsor":"G\u00f6teborg University","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SWEDEN","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"F. Prausnitzii","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"MetaboGen AB","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"MetaboGen AB \/ G\u00f6teborg University","highestDevelopmentStatusID":"1","companyTruncated":"MetaboGen AB \/ G\u00f6teborg University"},{"orgOrder":0,"company":"University of Aberdeen","sponsor":"YAKULT HONSHA CO LTD","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"UNITED KINGDOM","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"4'-Galactooligosaccharide","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"University of Aberdeen","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Aberdeen \/ YAKULT HONSHA CO LTD","highestDevelopmentStatusID":"1","companyTruncated":"University of Aberdeen \/ YAKULT HONSHA CO LTD"},{"orgOrder":0,"company":"Alpine Biotech LLC","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"GLP-1 Booster","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Alpine Biotech LLC","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Alpine Biotech LLC \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Alpine Biotech LLC \/ Undisclosed"},{"orgOrder":0,"company":"Mount Sinai Hospital, Canada","sponsor":"Mitacs","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"CANADA","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Human Donor Milk","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Mount Sinai Hospital, Canada","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Mount Sinai Hospital, Canada \/ Mitacs","highestDevelopmentStatusID":"1","companyTruncated":"Mount Sinai Hospital, Canada \/ Mitacs"},{"orgOrder":0,"company":"Qingdao University","sponsor":"Qingdao Hiser Medical Group","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"CHINA","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Hydrogen-Rich Water","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Qingdao University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Qingdao University \/ Qingdao Hiser Medical Group","highestDevelopmentStatusID":"1","companyTruncated":"Qingdao University \/ Qingdao Hiser Medical Group"},{"orgOrder":0,"company":"Caelus Pharmaceuticals BV","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"NETHERLANDS","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"Intestinimonas","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Caelus Pharmaceuticals BV","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Caelus Pharmaceuticals BV \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Caelus Pharmaceuticals BV \/ Undisclosed"},{"orgOrder":0,"company":"GYNOV","sponsor":"Laboratoire Drouot","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"FRANCE","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Isitol","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"GYNOV","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"GYNOV \/ Laboratoire Drouot","highestDevelopmentStatusID":"1","companyTruncated":"GYNOV \/ Laboratoire Drouot"},{"orgOrder":0,"company":"Kalin Health, LLC","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"KH-1","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Kalin Health, LLC","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kalin Health, LLC \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Kalin Health, LLC \/ Nutrasource"},{"orgOrder":0,"company":"Kriya Therapeutics","sponsor":"QVT","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Cell & Gene Therapy","year":"2020","type":"Series A Financing","leadProduct":"KT-A112","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Kriya Therapeutics","amount2":0.080000000000000002,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0.080000000000000002,"dosageForm":"Injection","sponsorNew":"Kriya Therapeutics \/ QVT","highestDevelopmentStatusID":"1","companyTruncated":"Kriya Therapeutics \/ QVT"},{"orgOrder":0,"company":"Glac Biotech Co., Ltd","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"TAIWAN","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"L. Salivarius AP-32","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Glac Biotech Co., Ltd","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Glac Biotech Co., Ltd \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Glac Biotech Co., Ltd \/ Undisclosed"},{"orgOrder":0,"company":"Leeds Beckett University","sponsor":"Cultech Ltd","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Probiotic","year":"2025","type":"Inapplicable","leadProduct":"Lactobacillus Acidophilus CUL60","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Leeds Beckett University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Leeds Beckett University \/ Cultech Ltd","highestDevelopmentStatusID":"1","companyTruncated":"Leeds Beckett University \/ Cultech Ltd"},{"orgOrder":0,"company":"Wecare Probiotics Co., Ltd.","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"CHINA","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Lactobacillus Rhamnosus LRa05","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Wecare Probiotics Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Wecare Probiotics Co., Ltd. \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Wecare Probiotics Co., Ltd. \/ Undisclosed"},{"orgOrder":0,"company":"Konstantinos Makrilakis, MD","sponsor":"Uni-Pharma","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Probiotic","year":"2023","type":"Inapplicable","leadProduct":"Lactolevure","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Konstantinos Makrilakis, MD","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Konstantinos Makrilakis, MD \/ Uni-Pharma","highestDevelopmentStatusID":"1","companyTruncated":"Konstantinos Makrilakis, MD \/ Uni-Pharma"},{"orgOrder":0,"company":"Sultan Qaboos University","sponsor":"Karolinska Institutet | Nova Biomedical","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"OMAN","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2023","type":"Inapplicable","leadProduct":"Magnesium Oxide","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Sultan Qaboos University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Sultan Qaboos University \/ Karolinska Institutet | Nova Biomedical","highestDevelopmentStatusID":"1","companyTruncated":"Sultan Qaboos University \/ Karolinska Institutet | Nova Biomedical"},{"orgOrder":0,"company":"Cambridge Glycoscience","sponsor":"Atlantia Food Clinical Trials","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"UNITED KINGDOM","productType":"Plant Extract\/Herbal","year":"2020","type":"Inapplicable","leadProduct":"Maize Cob Extract","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Cambridge Glycoscience","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Cambridge Glycoscience \/ Atlantia Food Clinical Trials","highestDevelopmentStatusID":"1","companyTruncated":"Cambridge Glycoscience \/ Atlantia Food Clinical Trials"},{"orgOrder":0,"company":"Fitoplancton Marino, S.L.","sponsor":"Fundaci\u00f3 Cl\u00ednic Barcelona | Fertypharm","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SPAIN","productType":"Plant Extract\/Herbal","year":"2021","type":"Inapplicable","leadProduct":"Marine Microalgae Tetraselmis Chuii","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Fitoplancton Marino, S.L.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Fitoplancton Marino, S.L. \/ Fundaci\u00f3 Cl\u00ednic Barcelona | Fertypharm","highestDevelopmentStatusID":"1","companyTruncated":"Fitoplancton Marino, S.L. \/ Fundaci\u00f3 Cl\u00ednic Barcelona | Fertypharm"},{"orgOrder":0,"company":"Microbio","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"TAIWAN","productType":"Dietary Supplement","year":"2020","type":"Inapplicable","leadProduct":"MBS","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Microbio","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Microbio \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Microbio \/ Undisclosed"},{"orgOrder":0,"company":"Dr. Sch\u00e4r AG \/ SPA","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"ITALY","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"MCT Fats","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Dr. Sch\u00e4r AG \/ SPA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Oil","sponsorNew":"Dr. Sch\u00e4r AG \/ SPA \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Dr. Sch\u00e4r AG \/ SPA \/ Undisclosed"},{"orgOrder":0,"company":"Dr. Sch\u00e4r AG \/ SPA","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"ITALY","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"MCT Fats","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Dr. Sch\u00e4r AG \/ SPA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Oil","sponsorNew":"Dr. Sch\u00e4r AG \/ SPA \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Dr. Sch\u00e4r AG \/ SPA \/ Undisclosed"},{"orgOrder":0,"company":"Teatis, Inc","sponsor":"Citruslabs","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Meal Replacement Shake","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Teatis, Inc","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Teatis, Inc \/ Citruslabs","highestDevelopmentStatusID":"1","companyTruncated":"Teatis, Inc \/ Citruslabs"},{"orgOrder":0,"company":"Nestle Health Sciences SA","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Sun Yat-sen University","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SWITZERLAND","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Milk","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Nestle Health Sciences SA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nestle Health Sciences SA \/ Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Sun Yat-sen University","highestDevelopmentStatusID":"1","companyTruncated":"Nestle Health Sciences SA \/ Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Sun Yat-sen University"},{"orgOrder":0,"company":"Danone Specialized Nutrition (M) Sdn Bhd","sponsor":"Universiti Putra Malaysia","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"MALAYSIA","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Milnutri Sure","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Danone Specialized Nutrition (M) Sdn Bhd","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Danone Specialized Nutrition (M) Sdn Bhd \/ Universiti Putra Malaysia","highestDevelopmentStatusID":"1","companyTruncated":"Danone Specialized Nutrition (M) Sdn Bhd \/ Universiti Putra Malaysia"},{"orgOrder":0,"company":"University of Southern California","sponsor":"Halyard Health | Wallace H. Coulter Foundation","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Protein","year":"2020","type":"Inapplicable","leadProduct":"Mixed-Meal","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"University of Southern California","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Southern California \/ Halyard Health | Wallace H. Coulter Foundation","highestDevelopmentStatusID":"1","companyTruncated":"University of Southern California \/ Halyard Health | Wallace H. Coulter Foundation"},{"orgOrder":0,"company":"Nestle Health Sciences SA","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SWITZERLAND","productType":"Plant Extract\/Herbal","year":"2021","type":"Inapplicable","leadProduct":"Mulberry Leaves Extract","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Nestle Health Sciences SA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nestle Health Sciences SA \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Nestle Health Sciences SA \/ Undisclosed"},{"orgOrder":0,"company":"Tereos","sponsor":"BioFortis","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SPAIN","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Non Digestible Carbohydrates","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Tereos","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Tereos \/ BioFortis","highestDevelopmentStatusID":"1","companyTruncated":"Tereos \/ BioFortis"},{"orgOrder":0,"company":"Nestle Health Sciences SA","sponsor":"Nestle Health Sciences SA","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SWITZERLAND","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Nutren Diabetes","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Nestle Health Sciences SA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nestle Health Sciences SA \/ Nestle Health Sciences SA","highestDevelopmentStatusID":"1","companyTruncated":"Nestle Health Sciences SA \/ Nestle Health Sciences SA"},{"orgOrder":0,"company":"Universitat de Lleida","sponsor":"Lactalis","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SPAIN","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Nutrition Supplement","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Universitat de Lleida","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Universitat de Lleida \/ Lactalis","highestDevelopmentStatusID":"1","companyTruncated":"Universitat de Lleida \/ Lactalis"},{"orgOrder":0,"company":"Novozymes","sponsor":"Biofortis M\u00e9rieux Nutriscience","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"DENMARK","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"NZ-GHMH-01","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Novozymes","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Novozymes \/ Biofortis M\u00e9rieux Nutriscience","highestDevelopmentStatusID":"1","companyTruncated":"Novozymes \/ Biofortis M\u00e9rieux Nutriscience"},{"orgOrder":0,"company":"Marathon Family Health Team","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"CANADA","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Optifast Dietary Supplement","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Marathon Family Health Team","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Marathon Family Health Team \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Marathon Family Health Team \/ Undisclosed"},{"orgOrder":0,"company":"University of Southern California","sponsor":"Pendulum Therapeutics","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Dietary Supplement","year":"2020","type":"Inapplicable","leadProduct":"Pendulum Glucose","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"University of Southern California","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Southern California \/ Pendulum Therapeutics","highestDevelopmentStatusID":"1","companyTruncated":"University of Southern California \/ Pendulum Therapeutics"},{"orgOrder":0,"company":"Ingredia S.A.","sponsor":"BioTeSys GmbH","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"FRANCE","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"Pep2dia","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Ingredia S.A.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Ingredia S.A. \/ BioTeSys GmbH","highestDevelopmentStatusID":"1","companyTruncated":"Ingredia S.A. \/ BioTeSys GmbH"},{"orgOrder":0,"company":"Ingredia S.A.","sponsor":"BioTeSys GmbH","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"FRANCE","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Pep2dia","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Ingredia S.A.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Ingredia S.A. \/ BioTeSys GmbH","highestDevelopmentStatusID":"1","companyTruncated":"Ingredia S.A. \/ BioTeSys GmbH"},{"orgOrder":0,"company":"Global Preventive Medicine Biotech Co., Ltd.","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Plant Extract\/Herbal","year":"2024","type":"Inapplicable","leadProduct":"Plant Extract","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Global Preventive Medicine Biotech Co., Ltd.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Global Preventive Medicine Biotech Co., Ltd. \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Global Preventive Medicine Biotech Co., Ltd. \/ Undisclosed"},{"orgOrder":0,"company":"EPAX NORWAY AS","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"NORWAY","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Polyunsaturated Fatty Acid","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"EPAX NORWAY AS","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"EPAX NORWAY AS \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"EPAX NORWAY AS \/ Undisclosed"},{"orgOrder":0,"company":"Steno Diabetes Center Copenhagen","sponsor":"Royal DSM","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"DENMARK","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"Pro-\/Prebiotic Mix","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Steno Diabetes Center Copenhagen","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Steno Diabetes Center Copenhagen \/ Royal DSM","highestDevelopmentStatusID":"1","companyTruncated":"Steno Diabetes Center Copenhagen \/ Royal DSM"},{"orgOrder":0,"company":"Greenyn Biotechnology","sponsor":"Taipei Medical University","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"TAIWAN","productType":"Plant Extract\/Herbal","year":"2023","type":"Inapplicable","leadProduct":"Pumpkin Seed Extract","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Greenyn Biotechnology","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Greenyn Biotechnology \/ Taipei Medical University","highestDevelopmentStatusID":"1","companyTruncated":"Greenyn Biotechnology \/ Taipei Medical University"},{"orgOrder":0,"company":"AgeX Therapeutics","sponsor":"Sernova","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Cell & Gene Therapy","year":"2020","type":"Collaboration","leadProduct":"Recombinant Pluripotent Stem Cell-Derived Pancreatic Islet Beta Cell","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"AgeX Therapeutics","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"AgeX Therapeutics \/ Sernova","highestDevelopmentStatusID":"1","companyTruncated":"AgeX Therapeutics \/ Sernova"},{"orgOrder":0,"company":"University of Aarhus","sponsor":"Arla Foods","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"DENMARK","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Sandwich with Butter-like Dairy Product with Intact Mfgm","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"University of Aarhus","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Aarhus \/ Arla Foods","highestDevelopmentStatusID":"1","companyTruncated":"University of Aarhus \/ Arla Foods"},{"orgOrder":0,"company":"Cambridge Glycoscience","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"UNITED KINGDOM","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"SFF","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Cambridge Glycoscience","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Cambridge Glycoscience \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Cambridge Glycoscience \/ Undisclosed"},{"orgOrder":0,"company":"Fitoplancton Marino, S.L.","sponsor":"Fundaci\u00f3 Cl\u00ednic Barcelona | Fertypharm","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SPAIN","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Sham","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Fitoplancton Marino, S.L.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Fitoplancton Marino, S.L. \/ Fundaci\u00f3 Cl\u00ednic Barcelona | Fertypharm","highestDevelopmentStatusID":"1","companyTruncated":"Fitoplancton Marino, S.L. \/ Fundaci\u00f3 Cl\u00ednic Barcelona | Fertypharm"},{"orgOrder":0,"company":"Wellizen Australia","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"AUSTRALIA","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"SRW Ndo1","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Wellizen Australia","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Wellizen Australia \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Wellizen Australia \/ Undisclosed"},{"orgOrder":0,"company":"Uplifting Results Labs Inc.","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"Supergut","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Uplifting Results Labs Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Uplifting Results Labs Inc. \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Uplifting Results Labs Inc. \/ Undisclosed"},{"orgOrder":0,"company":"Slimbiotics GmbH","sponsor":"Clinical Research Center Kiel GmbH","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"GERMANY","productType":"Probiotic","year":"2021","type":"Inapplicable","leadProduct":"Synbiotic","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Slimbiotics GmbH","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Slimbiotics GmbH \/ Clinical Research Center Kiel GmbH","highestDevelopmentStatusID":"1","companyTruncated":"Slimbiotics GmbH \/ Clinical Research Center Kiel GmbH"},{"orgOrder":0,"company":"Lo.Li.Pharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"FRANCE","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Tecadriol","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Lo.Li.Pharma","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Lo.Li.Pharma \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Lo.Li.Pharma \/ Undisclosed"},{"orgOrder":0,"company":"Children's Hospital of Fudan University","sponsor":"Adfontes (Shanghai) Bio-technology Co.,Ltd.","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"CHINA","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Trimtab","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Children's Hospital of Fudan University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Powder","sponsorNew":"Children's Hospital of Fudan University \/ Adfontes (Shanghai) Bio-technology Co.,Ltd.","highestDevelopmentStatusID":"1","companyTruncated":"Children's Hospital of Fudan University \/ Adfontes (Shanghai) Bio-technology Co.,Ltd."},{"orgOrder":0,"company":"Fytexia","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"FRANCE","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Verum A","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Fytexia","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Fytexia \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Fytexia \/ Undisclosed"},{"orgOrder":0,"company":"Fytexia","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"FRANCE","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Verum T1","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Fytexia","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Fytexia \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Fytexia \/ Undisclosed"},{"orgOrder":0,"company":"Viome","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Viome\\'S Precision Nutrition Program","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Viome","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Viome \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Viome \/ Undisclosed"},{"orgOrder":0,"company":"Viome","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Viome\\'S Precision Nutrition Program","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Viome","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Viome \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Viome \/ Undisclosed"},{"orgOrder":0,"company":"Medical University of Vienna","sponsor":"BIOGENA GmbH","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"AUSTRIA","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"Wasabi Leaf Powder","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Medical University of Vienna","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Medical University of Vienna \/ BIOGENA GmbH","highestDevelopmentStatusID":"1","companyTruncated":"Medical University of Vienna \/ BIOGENA GmbH"},{"orgOrder":0,"company":"Eden Miller","sponsor":"Pendulum Therapeutics","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"WBF-0031","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Eden Miller","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Eden Miller \/ Pendulum Therapeutics","highestDevelopmentStatusID":"1","companyTruncated":"Eden Miller \/ Pendulum Therapeutics"},{"orgOrder":0,"company":"Nestle Health Sciences SA","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SWITZERLAND","productType":"Protein","year":"2021","type":"Inapplicable","leadProduct":"Whey Protein","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Nestle Health Sciences SA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nestle Health Sciences SA \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Nestle Health Sciences SA \/ Undisclosed"},{"orgOrder":0,"company":"Medtronic Plc","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"Paracetamol","moa":"COX-1\/COX-2","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Medtronic Plc","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Medtronic Plc \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Medtronic Plc \/ Undisclosed"},{"orgOrder":0,"company":"Tulex Pharmaceutical","sponsor":"Eton Pharmaceuticals","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Hormone","year":"2023","type":"Acquisition","leadProduct":"Desmopressin Acetate","moa":"Vasopressin receptor","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Tulex Pharmaceutical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Tulex Pharmaceutical \/ Eton Pharmaceuticals","highestDevelopmentStatusID":"1","companyTruncated":"Tulex Pharmaceutical \/ Eton Pharmaceuticals"},{"orgOrder":0,"company":"Vedic Lifesciences","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"INDIA","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Vedic Lifesciences","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Vedic Lifesciences \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Vedic Lifesciences \/ Undisclosed"},{"orgOrder":0,"company":"Shenzhen Precision Health Food Technology Co. Ltd.,","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"CHINA","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Shenzhen Precision Health Food Technology Co. Ltd.,","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Shenzhen Precision Health Food Technology Co. Ltd., \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Shenzhen Precision Health Food Technology Co. Ltd., \/ Undisclosed"},{"orgOrder":0,"company":"University of Hong Kong","sponsor":"Health and Medical Research Fund | Primary Healthcare Office, Hong Kong","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"HONG KONG","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"University of Hong Kong","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Hong Kong \/ Health and Medical Research Fund | Primary Healthcare Office, Hong Kong","highestDevelopmentStatusID":"1","companyTruncated":"University of Hong Kong \/ Health and Medical Research Fund | Primary Healthcare Office, Hong Kong"},{"orgOrder":0,"company":"Chugai Pharmaceutical","sponsor":"Novo Nordisk","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"JAPAN","productType":"Undisclosed","year":"2020","type":"Licensing Agreement","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Chugai Pharmaceutical","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Chugai Pharmaceutical \/ Novo Nordisk","highestDevelopmentStatusID":"1","companyTruncated":"Chugai Pharmaceutical \/ Novo Nordisk"},{"orgOrder":0,"company":"Nutricia Inc","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"NETHERLANDS","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Nutricia Inc","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nutricia Inc \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Nutricia Inc \/ Undisclosed"},{"orgOrder":0,"company":"Fundaci\u00f3n P\u00fablica Andaluza para la Investigaci\u00f3n de M\u00e1laga","sponsor":"Adventia Pharma","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SPAIN","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Fundaci\u00f3n P\u00fablica Andaluza para la Investigaci\u00f3n de M\u00e1laga","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Fundaci\u00f3n P\u00fablica Andaluza para la Investigaci\u00f3n de M\u00e1laga \/ Adventia Pharma","highestDevelopmentStatusID":"1","companyTruncated":"Fundaci\u00f3n P\u00fablica Andaluza para la Investigaci\u00f3n de M\u00e1laga \/ Adventia Pharma"},{"orgOrder":0,"company":"Nestle Health Sciences SA","sponsor":"Peking Union Medical College Hospital","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SWITZERLAND","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Nestle Health Sciences SA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nestle Health Sciences SA \/ Peking Union Medical College Hospital","highestDevelopmentStatusID":"1","companyTruncated":"Nestle Health Sciences SA \/ Peking Union Medical College Hospital"},{"orgOrder":0,"company":"Sanofi","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"FRANCE","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Sanofi","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Sanofi \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Sanofi \/ Undisclosed"},{"orgOrder":0,"company":"Novo Nordisk","sponsor":"Massachusetts Institute of Technology","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"DENMARK","productType":"Undisclosed","year":"2022","type":"Collaboration","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Novo Nordisk","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Novo Nordisk \/ Massachusetts Institute of Technology","highestDevelopmentStatusID":"1","companyTruncated":"Novo Nordisk \/ Massachusetts Institute of Technology"},{"orgOrder":0,"company":"Quell Therapeutics","sponsor":"AstraZeneca","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"UNITED KINGDOM","productType":"Undisclosed","year":"2023","type":"Collaboration","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Quell Therapeutics","amount2":2.0899999999999999,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":2.0899999999999999,"dosageForm":"Undisclosed","sponsorNew":"Quell Therapeutics \/ AstraZeneca","highestDevelopmentStatusID":"1","companyTruncated":"Quell Therapeutics \/ AstraZeneca"},{"orgOrder":0,"company":"Mina Therapeutics","sponsor":"AstraZeneca","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"UNITED KINGDOM","productType":"Undisclosed","year":"2020","type":"Collaboration","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Mina Therapeutics","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Mina Therapeutics \/ AstraZeneca","highestDevelopmentStatusID":"1","companyTruncated":"Mina Therapeutics \/ AstraZeneca"},{"orgOrder":0,"company":"MRM Health","sponsor":"International Flavors and Fragrances","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"BELGIUM","productType":"Undisclosed","year":"2020","type":"Collaboration","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"MRM Health","amount2":0.02,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0.02,"dosageForm":"Undisclosed","sponsorNew":"MRM Health \/ International Flavors and Fragrances","highestDevelopmentStatusID":"1","companyTruncated":"MRM Health \/ International Flavors and Fragrances"},{"orgOrder":0,"company":"Tabuk Pharmaceuticals","sponsor":"Biocon","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"SAUDI ARABIA","productType":"Undisclosed","year":"2024","type":"Licensing Agreement","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Tabuk Pharmaceuticals","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Tabuk Pharmaceuticals \/ Biocon","highestDevelopmentStatusID":"1","companyTruncated":"Tabuk Pharmaceuticals \/ Biocon"},{"orgOrder":0,"company":"University of Alabama at Birmingham","sponsor":"University of Mississippi Medical Center | Cooper Green Mercy Health Services | Pack Health | National Institute on Minority Health and Health Disparities","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"University of Alabama at Birmingham","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Alabama at Birmingham \/ University of Mississippi Medical Center | Cooper Green Mercy Health Services | Pack Health | National Institute on Minority Health and Health Disparities","highestDevelopmentStatusID":"1","companyTruncated":"University of Alabama at Birmingham \/ University of Mississippi Medical Center | Cooper Green Mercy Health Services | Pack Health | National Institute on Minority Health and Health Disparities"},{"orgOrder":0,"company":"Semaine Health","sponsor":"Citruslabs","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Semaine Health","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Semaine Health \/ Citruslabs","highestDevelopmentStatusID":"1","companyTruncated":"Semaine Health \/ Citruslabs"},{"orgOrder":0,"company":"Habitual Health","sponsor":"Lindus Health","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Habitual Health","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Habitual Health \/ Lindus Health","highestDevelopmentStatusID":"1","companyTruncated":"Habitual Health \/ Lindus Health"},{"orgOrder":0,"company":"The Center for Applied Health Sciences, LLC","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"The Center for Applied Health Sciences, LLC","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"The Center for Applied Health Sciences, LLC \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"The Center for Applied Health Sciences, LLC \/ Undisclosed"},{"orgOrder":0,"company":"Unicity International, Inc.","sponsor":"Biofortis Innovation Services","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Unicity International, Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Unicity International, Inc. \/ Biofortis Innovation Services","highestDevelopmentStatusID":"1","companyTruncated":"Unicity International, Inc. \/ Biofortis Innovation Services"},{"orgOrder":0,"company":"Aspect Biosystems","sponsor":"Novo Nordisk","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"CANADA","productType":"Undisclosed","year":"2023","type":"Collaboration","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Aspect Biosystems","amount2":2.6800000000000002,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":2.6800000000000002,"dosageForm":"Undisclosed","sponsorNew":"Aspect Biosystems \/ Novo Nordisk","highestDevelopmentStatusID":"1","companyTruncated":"Aspect Biosystems \/ Novo Nordisk"},{"orgOrder":0,"company":"KayoThera","sponsor":"NIH NIDDK","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Undisclosed","year":"2023","type":"Funding","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"KayoThera","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KayoThera \/ NIH NIDDK","highestDevelopmentStatusID":"1","companyTruncated":"KayoThera \/ NIH NIDDK"},{"orgOrder":0,"company":"Regenxbio","sponsor":"Ultragenyx Pharmaceutical","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Undisclosed","year":"2020","type":"Licensing Agreement","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Regenxbio","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Regenxbio \/ Ultragenyx Pharmaceutical","highestDevelopmentStatusID":"1","companyTruncated":"Regenxbio \/ Ultragenyx Pharmaceutical"},{"orgOrder":0,"company":"Agence Sanitaire et Sociale de Nouvelle Cal\u00e9donie","sponsor":"Institut Pasteur | Pacific Community | World Health Organization | Institut de la Statitique et des Etudes Economiques Nouvelle Cal\u00e9donie","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Agence Sanitaire et Sociale de Nouvelle Cal\u00e9donie","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Agence Sanitaire et Sociale de Nouvelle Cal\u00e9donie \/ Institut Pasteur | Pacific Community | World Health Organization | Institut de la Statitique et des Etudes Economiques Nouvelle Cal\u00e9donie","highestDevelopmentStatusID":"1","companyTruncated":"Agence Sanitaire et Sociale de Nouvelle Cal\u00e9donie \/ Institut Pasteur | Pacific Community | World Health Organization | Institut de la Statitique et des Etudes Economiques Nouvelle Cal\u00e9donie"},{"orgOrder":0,"company":"Undisclosed","sponsor":"BIOSYENT PHARMA INC","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"","productType":"Undisclosed","year":"2024","type":"Licensing Agreement","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Undisclosed","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Undisclosed \/ BIOSYENT PHARMA INC","highestDevelopmentStatusID":"1","companyTruncated":"Undisclosed \/ BIOSYENT PHARMA INC"},{"orgOrder":0,"company":"Adalvo","sponsor":"AmbioPharm","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"MALTA","productType":"Undisclosed","year":"2020","type":"Licensing Agreement","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Adalvo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Adalvo \/ AmbioPharm","highestDevelopmentStatusID":"1","companyTruncated":"Adalvo \/ AmbioPharm"},{"orgOrder":0,"company":"Alpine Biotech","sponsor":"Lawry Han","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Alpine Biotech","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Alpine Biotech \/ Lawry Han","highestDevelopmentStatusID":"1","companyTruncated":"Alpine Biotech \/ Lawry Han"},{"orgOrder":0,"company":"Remedium Bio","sponsor":"Eli Lilly","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Cell & Gene Therapy","year":"2025","type":"Collaboration","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Remedium Bio","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Remedium Bio \/ Eli Lilly","highestDevelopmentStatusID":"1","companyTruncated":"Remedium Bio \/ Eli Lilly"},{"orgOrder":0,"company":"LMC Diabetes & Endocrinology","sponsor":"Abbott Laboratories","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"CANADA","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"LMC Diabetes & Endocrinology","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"LMC Diabetes & Endocrinology \/ Abbott Laboratories","highestDevelopmentStatusID":"1","companyTruncated":"LMC Diabetes & Endocrinology \/ Abbott Laboratories"},{"orgOrder":0,"company":"INQUIS Clinical Research","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"CANADA","productType":"Peptide, Unconjugated","year":"2025","type":"Inapplicable","leadProduct":"Collagen","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"INQUIS Clinical Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"INQUIS Clinical Research \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"INQUIS Clinical Research \/ Undisclosed"},{"orgOrder":0,"company":"QuickSilver Scientific","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"AMPK Charge Plus","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"QuickSilver Scientific","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"QuickSilver Scientific \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"QuickSilver Scientific \/ KGK Science"}]

    Find Novel Endocrinology Drugs in Clinical Development

    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Sanofi

                            France
                            CPhI WW Frankfurt
                            Attending
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Randomized Controlled Trial to Compare the Glycemic Control, With or Without the Connected Solution, of Adul...

                            Details : This drug candidate is currently being evaluated in clinical studies for the treatment of Diabetes Mellitus, Type 2.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            January 13, 2023

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            Sanofi Company Banner

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Alfred E Tiefenbacher GmbH

                            Germany
                            FNCE
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

                            Lead Product(s) : Vildagliptin

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Study Aims to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover D...

                            Details : Vildagliptin is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Diabetes Mellitus.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            April 15, 2022

                            Lead Product(s) : Vildagliptin

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            Tiefenbacher Compnay Banner

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Sanofi

                            France
                            CPhI WW Frankfurt
                            Attending
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

                            Lead Product(s) : Insulin Glargine,Lixisenatide

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            New Soliqua® Data Shows Improved Blood Sugar Control Without Weight Gain Versus Premixed Insulin

                            Details : Participants were randomized to switch from their prior insulin to either Soliqua once daily or premixed insulin twice daily, with starting doses determined and adjusted weekly. Any metformin or SGLT-2i treatment was maintained through the study period.

                            Product Name : Soliqua

                            Product Type : Peptide, Unconjugated

                            Upfront Cash : Inapplicable

                            June 28, 2021

                            Lead Product(s) : Insulin Glargine,Lixisenatide

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            Sanofi Company Banner

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Remedium Bio

                            U.S.A arrow
                            FNCE
                            Not Confirmed

                            Remedium Bio

                            U.S.A arrow
                            FNCE
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Sponsor : Eli Lilly

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            DEALS_DEV arrow-down

                            Lifespan Portfolio Company Remedium Signs Deal with ELI LILLY

                            Details : The collaboration aims to advance innovative gene therapies for Type 2 diabetes and obesity using Remedium's proprietary Prometheus™ platform.

                            Product Name : Undisclosed

                            Product Type : Cell & Gene Therapy

                            Upfront Cash : Undisclosed

                            September 23, 2025

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Sponsor : Eli Lilly

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            LMC Diabetes & Endocrinology

                            Country arrow
                            FNCE
                            Not Confirmed

                            LMC Diabetes & Endocrinology

                            Country arrow
                            FNCE
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Sponsor : Abbott Laboratories

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose Monitoring and Capillary Blood ...

                            Details : This drug candidate is currently being evaluated in Undisclosed clinical studies for the treatment of Diabetes Mellitus, Type 2.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            September 05, 2025

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Sponsor : Abbott Laboratories

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            Alpine Biotech

                            Country arrow
                            FNCE
                            Not Confirmed

                            Alpine Biotech

                            Country arrow
                            FNCE
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Sponsor : Lawry Han

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Glucagon Like Peptide 1 (GLP-1) Boosterâ„¢ RCT Study

                            Details : This drug candidate is currently being evaluated in clinical studies for the treatment of Hyperglycemia.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            August 26, 2025

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Sponsor : Lawry Han

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            07

                            Haisco Pharmaceutical

                            China arrow
                            FNCE
                            Not Confirmed

                            Haisco Pharmaceutical

                            China arrow
                            FNCE
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Cofrogliptin

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Safety and Efficacy Evaluation of Cofrogliptin (HSK7653) and Acarbose Research Among T2DMs

                            Details : Cofrogliptin is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Diabetes Mellitus, Type 2.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            August 14, 2025

                            Lead Product(s) : Cofrogliptin

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            08

                            The People's Hospital of Gaozhou

                            Country arrow
                            FNCE
                            Not Confirmed

                            The People's Hospital of Gaozhou

                            Country arrow
                            FNCE
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Amino Acids Mixture

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Sponsor : Chengdu Qingshan Likang Pharmaceutical

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic Patients

                            Details : Amino acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Diabetes Mellitus.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            July 22, 2025

                            Lead Product(s) : Amino Acids Mixture

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Sponsor : Chengdu Qingshan Likang Pharmaceutical

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            09

                            Richmond Pharmacology

                            Country arrow
                            FNCE
                            Not Confirmed

                            Richmond Pharmacology

                            Country arrow
                            FNCE
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Glucose

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Sponsor : Richmond Research Institute

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM

                            Details : Glucose is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Diabetes Mellitus, Type 2.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            June 11, 2025

                            Lead Product(s) : Glucose

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Sponsor : Richmond Research Institute

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            10

                            EPAX NORWAY AS

                            Norway arrow
                            FNCE
                            Not Confirmed

                            EPAX NORWAY AS

                            Norway arrow
                            FNCE
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Polyunsaturated Fatty Acid

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Effect of Supplementation With Fish Oil (EPAX EVOLVE 05) on Sperm Quality

                            Details : Polyunsaturated Fatty Acid is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Infertility, Male.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            April 30, 2025

                            Lead Product(s) : Polyunsaturated Fatty Acid

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth